Neoplasms Metastasis Completed Phase 2 Trials for Tanezumab (DB12335)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00545129A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To BoneTreatment